 |
Selenium (Se) is a part of the enzyme glutathione peroxidase, which metabolizes hydroperoxides formed from polyunsaturated fatty acids. Selenium is also a part of the enzymes that deiodinate thyroid hormones. Generally, selenium acts as an antioxidant that works with vitamin E. Some epidemiologic studies associate low selenium levels with cancer. In children with Down syndrome, selenium supplements may help prevent bacterial infections. Plasma levels vary from 8 to 25 μg/dL, depending on selenium intake. Diagnosis is usually clinical; sometimes blood glutathione peroxidase is measured.
Deficiency:
Deficiency is rare, even in New Zealand and Finland, where selenium intake is 30 to 50 μg/day, compared with 100 to 250 μg/day in the US and Canada. In certain areas of China, where intake averages 10 to 15 μg/day, selenium deficiency predisposes patients to Keshan disease, an endemic viral cardiomyopathy affecting primarily children and young women. This cardiomyopathy can be prevented but not cured by sodium selenite supplements of 50 μg/day po. Patients receiving long-term TPN have developed selenium deficiency with muscle pain and tenderness that responded to a selenomethionine supplement. In Siberian Russia and China, growing children with selenium deficiency may develop chronic osteoarthropathy (Kashin-Beck disease). Selenium deficiency may contribute synergistically with iodine deficiency to the development of goiter and hypothyroidism.
Diagnosis is made clinically or sometimes by measuring glutathione peroxidase activity or plasma selenium, but neither of these tests is readily available. Treatment consists of sodium selenite 100 μg/day po.
Toxicity:
At high doses (> 900 μg/day), selenium causes toxicity. Manifestations include hair loss, abnormal nails, dermatitis, peripheral neuropathy, nausea, diarrhea, fatigue, irritability, and a garlic odor of the breath. Toxic levels of plasma selenium are not well defined.
Last full review/revision August 2008 by Larry E. Johnson, MD, PhD
Content last modified February 2012
| |
|
